Last news
The CMA Opens the Capital Market to All Categories of Foreign Investors

The CMA Opens the Capital Market to All Categories of Foreign Investors

Notified -...

Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

Notified -...

BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter

BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter

Notified -...

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

Notified -...

Bitget Opens TradFi Trading to All Users After Record-Breaking Beta Demand

Bitget Opens TradFi Trading to All Users After Record-Breaking Beta Demand

Notified -...

Pluxee Q1 Fiscal 2026 Revenues - Robust start in the 1st quarter delivering on expectations, All Fiscal 2026 financial objectives confirmed

Pluxee Q1 Fiscal 2026 Revenues - Robust start in the 1st quarter delivering on expectations, All Fiscal 2026 financial objectives confirmed

Notified -...

GDU Launches UAV-P300, The World’s First Drone with AI-Driven Optical & Electronic Fog Penetration Capabilities

GDU Launches UAV-P300, The World’s First Drone with AI-Driven Optical & Electronic Fog Penetration Capabilities

Notified -...

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

Notified -...

1 ... 25 26 27 28 29 30 31 32 33 ... 1006
menu
menu